PHF15 inhibitors belong to a class of chemical compounds designed to target and modulate the activity of the PHF15 protein. PHF15, short for PHD finger protein 15, is a member of the PHD finger family of proteins that play crucial roles in the regulation of gene expression and chromatin structure. Specifically, PHF15 is involved in epigenetic regulation, which is the process by which gene expression is controlled without altering the underlying DNA sequence. PHF15 contains a PHD (Plant Homeodomain) finger domain, a structural motif known to interact with histone proteins and chromatin, making it a key player in epigenetic mechanisms.
PHF15 inhibitors are designed to selectively bind to PHF15, either disrupting its interactions with other proteins or altering its conformation to hinder its normal function. By doing so, these inhibitors can potentially influence the epigenetic regulation of target genes associated with various cellular processes. These compounds are a part of ongoing research efforts in the field of molecular biology and epigenetics, aiming to unravel the intricate mechanisms of gene expression and chromatin dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
JIB 04 | 199596-05-9 | sc-397040 | 20 mg | $177.00 | ||
JIB-04 is a pan-KDM inhibitor that can inhibit various demethylases, including potentially JADE2. It binds non-competitively, leading to altered gene expression through changes in histone methylation. | ||||||
GSK J1 | 1373422-53-7 | sc-391113 sc-391113A | 10 mg 50 mg | $193.00 $813.00 | ||
GSK-J1 is a selective inhibitor for the KDM6/KDM5 family. Although it is more potent against KDM6, it can potentially affect JADE2 activity due to its mechanism of competitive inhibition. | ||||||